Skip to main content

Papillary and Epithelial–Myoepithelial Tumors

  • Chapter
  • First Online:
A Comprehensive Guide to Core Needle Biopsies of the Breast

Abstract

This chapter will provide an overview of the various types of benign and malignant papillary lesions as well as epithelial–myoepithelial lesions with a focus on diagnosis in a core biopsy sample. Traditionally, the standard practice has been to excise any papillary or epithelial–myoepithelial lesions. In recent years, data have shown low upgrade rates on excision when benign papillomas are diagnosed in a core biopsy, and there has been a trend to not excising papillomas. A conservative approach to interpreting core biopsies containing atypical papillary lesions and papillary carcinomas is prudent. This is particularly true in assessing the presence or absence of an invasive component in a papillary carcinoma, which is usually easier when the entire lesion can be evaluated. Clinical presentations, imaging features, and differential diagnoses for these lesions will also be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol. 2005;123(1):36–44.

    PubMed  Google Scholar 

  2. Francis A, England D, Rowlands D, Bradley S. Breast papilloma: mammogram, ultrasound and MRI appearances. Breast. 2002;11(5):394–7.

    CAS  PubMed  Google Scholar 

  3. Carty NJ, Mudan SS, Ravichandran D, Royle GT, Taylor I. Prospective study of outcome in women presenting with nipple discharge. Ann R Coll Surg Engl. 1994;76(6):387–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Orel SG, Dougherty CS, Reynolds C, Czerniecki BJ, Siegelman ES, Schnall MD. MR imaging in patients with nipple discharge: initial experience. Radiology. 2000;216(1):248–54.

    CAS  PubMed  Google Scholar 

  5. Han BK, Choe YH, Ko YH, Yang JH, Nam SJ. Benign papillary lesions of the breast: sonographic-pathologic correlation. J Ultrasound Med. 1999;18(3):217–23.

    CAS  PubMed  Google Scholar 

  6. Flint A, Oberman HA. Infarction and squamous metaplasia of intraductal papilloma: a benign breast lesion that may simulate carcinoma. Hum Pathol. 1984;15(8):764–7.

    CAS  PubMed  Google Scholar 

  7. Lewis JT, Hartmann LC, Vierkant RA, Maloney SD, Shane Pankratz V, Allers TM, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol. 2006;30(6):665–72.

    PubMed  Google Scholar 

  8. MacGrogan G, Tavassoli FA. Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch. 2003;443(5):609–17.

    CAS  PubMed  Google Scholar 

  9. Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 1996;78(2):258–66.

    CAS  PubMed  Google Scholar 

  10. WHO Classification of Tumors. Breast tumours. 5th ed. Lyon: IARC; 2019.

    Google Scholar 

  11. Lininger RA, Park WS, Man YG, Pham T, MacGrogan G, Zhuang Z, et al. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. Hum Pathol. 1998;29(10):1113–8.

    CAS  PubMed  Google Scholar 

  12. Troxell ML, Levine J, Beadling C, Warrick A, Dunlap J, Presnell A, et al. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod Pathol. 2010;23(1):27–37.

    CAS  PubMed  Google Scholar 

  13. Jahn SW, Kashofer K, Thuringer A, Abete L, Winter E, Eidenhammer S, et al. Mutation profiling of usual ductal hyperplasia of the breast reveals activating mutations predominantly at different levels of the PI3K/AKT/mTOR pathway. Am J Pathol. 2016;186(1):15–23.

    CAS  PubMed  Google Scholar 

  14. Kader T, Elder K, Zethoven M, Semple T, Hill P, Goode DL, et al. The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma. NPJ Breast Cancer. 2020;6:9.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Mishima C, Kagara N, Ikeda JI, Morii E, Miyake T, Tanei T, et al. Mutational analysis of AKT1 and PIK3CA in intraductal papillomas of the breast with special reference to cellular components. Am J Pathol. 2018;188(5):1106–12.

    CAS  PubMed  Google Scholar 

  16. Jakate K, De Brot M, Goldberg F, Muradali D, O’Malley FP, Mulligan AM. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses. Am J Surg Pathol. 2012;36(4):544–51.

    PubMed  Google Scholar 

  17. Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol. 2004;122(2):217–21.

    PubMed  Google Scholar 

  18. Swapp RE, Glazebrook KN, Jones KN, Brandts HM, Reynolds C, Visscher DW, et al. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013;20(6):1900–5.

    PubMed  Google Scholar 

  19. Rizzo M, Linebarger J, Lowe MC, Pan L, Gabram SG, Vasquez L, et al. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up. J Am Coll Surg. 2012;214(3):280–7.

    PubMed  Google Scholar 

  20. Jaffer S, Nagi C, Bleiweiss IJ. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy. Cancer. 2009;115(13):2837–43.

    PubMed  Google Scholar 

  21. Tseng HS, Chen YL, Chen ST, Wu YC, Kuo SJ, Chen LS, et al. The management of papillary lesion of the breast by core needle biopsy. Eur J Surg Oncol. 2009;35(1):21–4.

    CAS  PubMed  Google Scholar 

  22. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008;52(1):20–9.

    CAS  PubMed  Google Scholar 

  23. Pareja F, Corben AD, Brennan SB, Murray MP, Bowser ZL, Jakate K, et al. Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: rate of upgrade to carcinoma at excision. Cancer. 2016;122(18):2819–27.

    PubMed  Google Scholar 

  24. Lee SJ, Wahab RA, Sobel LD, Zhang B, Brown AL, Lewis K, et al. Analysis of 612 benign papillomas diagnosed at core biopsy: rate of upgrade to malignancy, factors associated with upgrade, and a proposal for selective surgical excision. AJR Am J Roentgenol. 2021;217:1299–311.

    PubMed  Google Scholar 

  25. Kim SY, Kim EK, Lee HS, Kim MJ, Yoon JH, Koo JS, et al. Asymptomatic benign papilloma without atypia diagnosed at ultrasonography-guided 14-gauge core needle biopsy: which subgroup can be managed by observation? Ann Surg Oncol. 2016;23(6):1860–6.

    PubMed  Google Scholar 

  26. Nakhlis F, Baker GM, Pilewskie M, Gelman R, Calvillo KZ, Ludwig K, et al. The incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in situ in patients with intraductal papilloma without atypia on core biopsy: results from a prospective multi-institutional registry (TBCRC 034). Ann Surg Oncol. 2021;28(5):2573–8.

    PubMed  Google Scholar 

  27. Limberg J, Kucher W, Fasano G, Hoda S, Michaels A, Marti JL. Intraductal papilloma of the breast: prevalence of malignancy and natural history under active surveillance. Ann Surg Oncol. 2021;28:6032–40.

    PubMed  Google Scholar 

  28. Grimm LJ, Bookhout CE, Bentley RC, Jordan SG, Lawton TJ. Concordant, non-atypical breast papillomas do not require surgical excision: a 10-year multi-institution study and review of the literature. Clin Imaging. 2018;51:180–5.

    PubMed  Google Scholar 

  29. Amin MB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. American Joint Committee on Cancer, Springer: Chicago IL; 2017.

    Google Scholar 

  30. Rakha EA, Varga Z, Elsheik S, Ellis IO. High-grade encapsulated papillary carcinoma of the breast: an under-recognized entity. Histopathology. 2015;66(5):740–6.

    PubMed  Google Scholar 

  31. Esposito NN, Dabbs DJ, Bhargava R. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases. Am J Clin Pathol. 2009;131(2):228–42.

    PubMed  Google Scholar 

  32. Rakha EA, Gandhi N, Climent F, van Deurzen CH, Haider SA, Dunk L, et al. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis. Am J Surg Pathol. 2011;35(8):1093–103.

    PubMed  Google Scholar 

  33. Tan BY, Thike AA, Ellis IO, Tan PH. Clinicopathologic characteristics of solid papillary carcinoma of the breast. Am J Surg Pathol. 2016;40(10):1334–42.

    PubMed  Google Scholar 

  34. Duprez R, Wilkerson PM, Lacroix-Triki M, Lambros MB, MacKay A, A’Hern R, et al. Immunophenotypic and genomic characterization of papillary carcinomas of the breast. J Pathol. 2012;226(3):427–41.

    CAS  PubMed  Google Scholar 

  35. Piscuoglio S, Ng CK, Martelotto LG, Eberle CA, Cowell CF, Natrajan R, et al. Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast. Mol Oncol. 2014;8(8):1588–602.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Schwartz CJ, Boroujeni AM, Khodadadi-Jamayran A, Heguy A, Snuderl M, Jour G, et al. Molecular analysis of encapsulated papillary carcinoma of the breast with and without invasion. Hum Pathol. 2021;111:67–74.

    CAS  PubMed  Google Scholar 

  37. Lec’ene AL. Observation d’un cas de tumeur “mixte” du sein. Rev Chir. 1906;33:434–8.

    Google Scholar 

  38. John BJ, Griffiths C, Ebbs SR. Pleomorphic adenoma of the breast should be excised with a cuff of normal tissue. Breast J. 2007;13(4):418–20.

    PubMed  Google Scholar 

  39. Sato K, Ueda Y, Shimasaki M, Ozaki M, Nitta N, Chada K, et al. Pleomorphic adenoma (benign mixed tumor) of the breast: a case report and review of the literature. Pathol Res Pract. 2005;201(4):333–9.

    PubMed  Google Scholar 

  40. Takahashi K. Diagnosis of an extremely rare pleomorphic adenoma of the breast with core needle biopsy: A case report. Ann Med Surg (Lond). 2018;36:242–5.

    PubMed  Google Scholar 

  41. Teh J, Dessauvagie B, Kessell M, Dissanayake D, Wylie EJ. An atypically located pleomorphic adenoma: radiological and pathological correlation. J Med Imaging Radiat Oncol. 2022;66:105–6.

    PubMed  Google Scholar 

  42. Diaz NM, McDivitt RW, Wick MR. Pleomorphic adenoma of the breast: a clinicopathologic and immunohistochemical study of 10 cases. Hum Pathol. 1991;22(12):1206–14.

    CAS  PubMed  Google Scholar 

  43. Foschini MP, Morandi L, Asioli S, Giove G, Corradini AG, Eusebi V. The morphological spectrum of salivary gland type tumours of the breast. Pathology. 2017;49(2):215–27.

    PubMed  Google Scholar 

  44. Moran CA, Suster S, Carter D. Benign mixed tumors (pleomorphic adenomas) of the breast. Am J Surg Pathol. 1990;14(10):913–21.

    CAS  PubMed  Google Scholar 

  45. Kanter MH, Sedeghi M. Pleomorphic adenoma of the breast: cytology of fine-needle aspiration and its differential diagnosis. Diagn Cytopathol. 1993;9(5):555–8.

    CAS  PubMed  Google Scholar 

  46. Narita T, Matsuda K. Pleomorphic adenoma of the breast: case report and review of the literature. Pathol Int. 1995;45(6):441–7.

    CAS  PubMed  Google Scholar 

  47. Cuadros CL, Ryan SS, Miller RE. Benign mixed tumor (pleomorphic adenoma) of the breast: ultrastructural study and review of the literature. J Surg Oncol. 1987;36(1):58–63.

    CAS  PubMed  Google Scholar 

  48. De Dominicis E, Perrone G, Verzi A, Bianchi A, Altomare V, Zobel BB, et al. Pleomorphic adenoma of the breast. Breast J. 2005;11(6):513–4.

    PubMed  Google Scholar 

  49. Ginter PS, Scognamiglio T, Tauchi-Nishi P, Antonio LB, Hoda SA. Pleomorphic adenoma of breast: a radiological and pathological study of a common tumor in an uncommon location. Case Rep Pathol. 2015;2015:172750.

    PubMed  PubMed Central  Google Scholar 

  50. Iyengar P, Cody HS 3rd, Brogi E. Pleomorphic adenoma of the breast: case report and review of the literature. Diagn Cytopathol. 2005;33(6):416–20.

    CAS  PubMed  Google Scholar 

  51. Khamechian T, Alizargar J, Mazoochi T. Reporting a rare case of pleomorphic adenoma of the breast. Case Rep Med. 2014;2014:387183.

    PubMed  PubMed Central  Google Scholar 

  52. Kelten C, Boyaci C, Trabulus DC, Sirin S. Benign mixed tumour of the breast and breast skin, two cases with diagnostic difficulties. BMJ Case Rep. 2015;2015 https://doi.org/10.1136/bcr-2015-210906.

  53. Fiks T. Pleomorphic adenoma (benign “mixed” tumor) of the human female breast. Case report. Pol J Pathol. 1999;50(4):297–9.

    CAS  PubMed  Google Scholar 

  54. Di Bonito M, Cantile M, Cerrone M, Liguori G, Botti G. Synchronous pleomorphic adenoma and invasive ductal carcinoma in distinct breasts. Breast J. 2015;21(4):428–30.

    PubMed  Google Scholar 

  55. Mizukami Y, Takayama T, Takemura A, Ichikawa K, Onoguchi M, Miyati T, et al. Pleomorphic adenoma of the breast. Radiat Med. 2008;26(7):442–5.

    PubMed  Google Scholar 

  56. Arslan A, Guldogan N, Kapucuoglu N, Esen G, Kara H, Uras C. A rare case of pleomorphic adenoma of the breast: ultrasonography and pathology findings. Breast J. 2018;24(6):1069–70.

    PubMed  Google Scholar 

  57. Rakha EA, Aleskandarany MA, Samaka RM, Hodi Z, Lee AH, Ellis IO. Pleomorphic adenoma-like tumour of the breast. Histopathology. 2016;68(3):405–10.

    PubMed  Google Scholar 

  58. Sakuma T, Mori M, Kokubo C, Deguchi K, Matsuo K, Tagami K. Cytology of breast pleomorphic adenoma associated with extensive apocrine metaplasia. Diagn Cytopathol. 2018;46(1):56–8.

    PubMed  Google Scholar 

  59. Molland JG, Morgan GJ, Walker DM, Lin BP. Pleomorphic adenoma of the parotid and breast in a male patient. Pathology. 2005;37(3):263–5.

    CAS  PubMed  Google Scholar 

  60. Reid-Nicholson M, Bleiweiss I, Pace B, Azueta V, Jaffer S. Pleomorphic adenoma of the breast. A case report and distinction from mucinous carcinoma. Arch Pathol Lab Med. 2003;127(4):474–7.

    CAS  PubMed  Google Scholar 

  61. Hayes MM, Lesack D, Girardet C, Del Vecchio M, Eusebi V. Carcinoma ex-pleomorphic adenoma of the breast. Report of three cases suggesting a relationship to metaplastic carcinoma of matrix-producing type. Virchows Arch. 2005;446(2):142–9.

    PubMed  Google Scholar 

  62. Chen KT. Pleomorphic adenoma of the breast. Am J Clin Pathol. 1990;93(6):792–4.

    CAS  PubMed  Google Scholar 

  63. Pia-Foschini M, Reis-Filho JS, Eusebi V, Lakhani SR. Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol. 2003;56(7):497–506.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Geurts JM, Schoenmakers EF, Roijer E, Stenman G, Van de Ven WJ. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res. 1997;57(1):13–7.

    CAS  PubMed  Google Scholar 

  65. Rohen C, Rogalla P, Meyer-Bolte K, Bartnitzke S, Chilla R, Bullerdiek J. Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements. Cancer Genet Cytogenet. 1999;111(2):178–81.

    CAS  PubMed  Google Scholar 

  66. Soreide JA, Anda O, Eriksen L, Holter J, Kjellevold KH. Pleomorphic adenoma of the human breast with local recurrence. Cancer. 1988;61(5):997–1001.

    CAS  PubMed  Google Scholar 

  67. Hamperl H. The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol. 1970;53:161–220.

    CAS  PubMed  Google Scholar 

  68. Lee JH, Kim SH, Kang BJ, Lee AW, Song BJ. Ultrasonographic features of benign adenomyoepithelioma of the breast. Korean J Radiol. 2010;11(5):522–7.

    PubMed  PubMed Central  Google Scholar 

  69. Berna JD, Arcas I, Ballester A, Bas A. Adenomyoepithelioma of the breast in a male. AJR Am J Roentgenol. 1997;169(3):917–8.

    CAS  PubMed  Google Scholar 

  70. Tamura G, Monma N, Suzuki Y, Satodate R, Abe H. Adenomyoepithelioma (myoepithelioma) of the breast in a male. Hum Pathol. 1993;24(6):678–81.

    CAS  PubMed  Google Scholar 

  71. Foschini MP, Eusebi V. Carcinomas of the breast showing myoepithelial cell differentiation. A review of the literature. Virchows Arch. 1998;432(4):303–10.

    CAS  PubMed  Google Scholar 

  72. Rosen PP. Adenomyoepithelioma of the breast. Hum Pathol. 1987;18(12):1232–7.

    CAS  PubMed  Google Scholar 

  73. Tavassoli FA. Myoepithelial lesions of the breast. Myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am J Surg Pathol. 1991;15(6):554–68.

    CAS  PubMed  Google Scholar 

  74. Hayes MM. Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation. J Clin Pathol. 2011;64(6):477–84.

    PubMed  Google Scholar 

  75. Moritz AW, Wiedenhoefer JF, Profit AP, Jagirdar J. Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: a case series emphasizing histologic, radiologic, and clinical correlation. Breast. 2016;29:132–9.

    PubMed  Google Scholar 

  76. Yang W, Wells J, Nguyen M, Shin SJ. Immunohistochemical characterization of adenomyoepithelial tumors of the breast (Abstract); 2014.

    Google Scholar 

  77. Ericson-Lindquist K, Johansson A, Leveen P, Elmberger G, Jonsson G, Staaf J, et al. Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series. Diagn Pathol. 2017;12(1):31.

    PubMed  PubMed Central  Google Scholar 

  78. Baum JE, Sung KJ, Tran H, Song W, Ginter PS. Mammary epithelial-myoepithelial carcinoma: report of a case with HRAS and PIK3CA mutations by next-generation sequencing. Int J Surg Pathol. 2019;27(4):441–5.

    CAS  PubMed  Google Scholar 

  79. Geyer FC, Li A, Papanastasiou AD, Smith A, Selenica P, Burke KA, et al. Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas. Nat Commun. 2018;9(1):1816.

    PubMed  PubMed Central  Google Scholar 

  80. Ginter PS, McIntire PJ, Kurtis B, Mirabelli S, Motanagh S, Hoda S, et al. Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity. Mod Pathol. 2020;33(9):1764–72.

    CAS  PubMed  Google Scholar 

  81. Lubin D, Toorens E, Zhang PJ, Jaffer S, Baraban E, Bleiweiss IJ, et al. Adenomyoepitheliomas of the breast frequently harbor recurrent hotspot mutations in PIK3-AKT pathway-related genes and a subset show genetic similarity to salivary gland epithelial-myoepithelial carcinoma. Am J Surg Pathol. 2019;43(7):1005–13.

    PubMed  Google Scholar 

  82. Xu J, Tang X, Iida Y, Fuchinoue F, Kusumi T, Yagihashi N, et al. Adenomyoepithelioma with carcinoma of the breast: a report of two cases and a review of the literature. Pathol Res Pract. 2016;212(2):130–4.

    PubMed  Google Scholar 

  83. Honda Y, Iyama K. Malignant adenomyoepithelioma of the breast combined with invasive lobular carcinoma. Pathol Int. 2009;59(3):179–84.

    PubMed  Google Scholar 

  84. Oka K, Sando N, Moriya T, Yatabe Y. Malignant adenomyoepithelioma of the breast with matrix production may be compatible with one variant form of matrix-producing carcinoma: a case report. Pathol Res Pract. 2007;203(8):599–604.

    PubMed  Google Scholar 

  85. Foschini MP, Pizzicannella G, Peterse JL, Eusebi V. Adenomyoepithelioma of the breast associated with low-grade adenosquamous and sarcomatoid carcinomas. Virchows Arch. 1995;427(3):243–50.

    CAS  PubMed  Google Scholar 

  86. Ahmed AA, Heller DS. Malignant adenomyoepithelioma of the breast with malignant proliferation of epithelial and myoepithelial elements: a case report and review of the literature. Arch Pathol Lab Med. 2000;124(4):632–6.

    CAS  PubMed  Google Scholar 

  87. Jones C, Tooze R, Lakhani SR. Malignant adenomyoepithelioma of the breast metastasizing to the liver. Virchows Arch. 2003;442(5):504–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy M. D’Alfonso .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ginter, P.S., D’Alfonso, T.M. (2022). Papillary and Epithelial–Myoepithelial Tumors. In: Shin, S.J., Chen, YY., Ginter, P.S. (eds) A Comprehensive Guide to Core Needle Biopsies of the Breast . Springer, Cham. https://doi.org/10.1007/978-3-031-05532-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-05532-4_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-05531-7

  • Online ISBN: 978-3-031-05532-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics